Chemoinformaics analysis of Angeloylgomisin P
| Molecular Weight | 514.571 | nRot | 6 |
| Heavy Atom Molecular Weight | 480.299 | nRig | 24 |
| Exact Molecular Weight | 514.22 | nRing | 4 |
| Solubility: LogS | -5.304 | nHRing | 1 |
| Solubility: LogP | 3.668 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 71 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 37 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 28 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 12 |
| nHA | 9 | APOL | 76.649 |
| nHD | 1 | BPOL | 47.129 |
| QED | 0.437 |
| Synth | 4.139 |
| Natural Product Likeliness | 2.263 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.691 |
| MDCK | 0.0000254 |
| BBB | 0.065 |
| PPB | 0.799221 |
| VDSS | 0.94 |
| FU | 0.134647 |
| CYP1A2-inh | 0.128 |
| CYP1A2-sub | 0.98 |
| CYP2c19-inh | 0.966 |
| CYP2c19-sub | 0.883 |
| CYP2c9-inh | 0.893 |
| CYP2c9-sub | 0.895 |
| CYP2d6-inh | 0.204 |
| CYP2d6-sub | 0.728 |
| CYP3a4-inh | 0.948 |
| CYP3a4-sub | 0.872 |
| CL | 4.592 |
| T12 | 0.165 |
| hERG | 0.074 |
| Ames | 0.029 |
| ROA | 0.07 |
| SkinSen | 0.091 |
| Carcinogencity | 0.061 |
| EI | 0.235 |
| Respiratory | 0.603 |
| NR-Aromatase | 0.629 |
| Antiviral | Yes |
| Prediction | 0.924146 |